Skip to main content
EQT Logo
Current Portfolio

BioArctic

BioArctic AB (publ) is an innovative Swedish biopharma company focusing on research and develop into neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and ALS.)

Key Facts
Sector

Life Sciences

Country

Sweden

Fund

LSP Dementia Fund

Entry

2025

Website

BioArtic

Responsible Partner

Philip Scheltens

Philip Scheltens

Partner and Head of Dementia Fund

About

Do You Want to Know More?

We are eager to explore how we can achieve great things together.